← All Stories
Fundraising

Venture-Backed Startups File for IPOs in Semiconductors and Clean Energy

Recent public S-1 filings show venture-backed companies in AI semiconductors, nuclear power, biotech, and space tech pursuing IPOs, according to Crunchbase News.

Armchairs at table with green plant placed near wall with creative signboard in modern conference room with window in office
Photo by Max Vakhtbovych on Pexels

Venture-Backed IPO Filings Surge in Key Sectors

In recent weeks, several venture-backed startups have filed public S-1 documents, including Cerebras Systems, which filed last week for an offering expected to raise around $2 billion and seeks a valuation upwards of $35 billion, according to Crunchbase News. This activity spans sectors like semiconductors, nuclear and geothermal power, biotech, and space and defense tech, with filings from companies such as X-energy and Fervo Energy highlighting a thawing IPO pipeline.

Semiconductor and AI Highlights

Cerebras Systems, a Silicon Valley company designing AI inference chips, filed publicly last week for an IPO that would be the largest initial share offering of a U.S. semiconductor company to date, as per Crunchbase data. The company had withdrawn IPO plans last fall but is now pursuing this offering, which underscores growing interest in AI technologies.

Clean Energy Companies Enter the Market

Nuclear power startup X-energy, based in Rockville, Maryland, made its debut today by pricing shares at $23 each, above the projected range, and raised around $1 billion, with shares closing up 27% in first-day trading. Meanwhile, Fervo Energy, a Houston-based geothermal power company, filed last week for a Nasdaq offering that Renaissance Capital estimates could raise around $250 million.

Biotech IPOs Gain Momentum

Last week, Kailera Therapeutics, a Waltham, Massachusetts-based developer of treatments for obesity and metabolic disease, raised $718 million in its Nasdaq offering. Alamar Biosciences, based in Fremont, California, and focused on proteomics for early disease detection, entered the market with a current market cap around $1.6 billion, according to Crunchbase News. Additionally, Mobia Medical in Austin filed last week for an offering, while Seaport Therapeutics in Boston and Hemab in Denmark filed the prior week for treatments related to neuropsychiatric disorders and blood coagulation, respectively.

Space and Defense Tech Filings

SpaceX, the Texas-based company, filed confidentially a few weeks ago for an IPO with a reported target valuation around $1.75 trillion and potential June debut, which could lead to a public filing soon. In contrast, HawkEye 360, a Herndon, Virginia-based developer of radio frequency intelligence for military customers, filed earlier this month for a New York Stock Exchange offering, amid increased investor interest in defense tech. As widely known, IPOs in defense sectors often reflect broader geopolitical demands for advanced technologies.

Sources
Topics
  • #IPOs
  • #Venture Capital
  • #Semiconductors
  • #Biotech
  • #Clean Energy
Get capital raising signals before they hit the news.
Join Waitlist